Seeking Alpha
02 Aug 2026, 03:59 UTC · 2h ago
Balchem: It's A Buy From Me After Posting Strong Q2 Results
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Seeking Alpha
02 Aug 2026, 03:59 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Balchem Corporation's Q2 EPS of $1.49 beat estimates by $0.07 and grew 11% year-over-year. — An earnings beat and double-digit YoY growth typically trigger positive price action for the specific equity.
+0.60All business segments posted revenue growth between 8.9% and 15%. — Broad-based growth across all segments indicates strong fundamental demand and reduces concentration risk.
+0.40The stock is estimated to be trading at a 9% discount to its fair value based on a FCF valuation model. — A perceived undervaluation suggests an upside opportunity for buyers, though it is based on a subjective model.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
The company beat EPS estimates, showed strong YoY growth across all segments, and is trading at a discount to fair value.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
3h ago
